相参频率捷变雷达目标稀疏重建性能边界综述

相比频率固定的脉冲多普勒体制, 频率捷变体制在抗干扰方面具有显著优势。但在该体制下, 基于匹配滤波的信号处理算法存在旁瓣平台问题, 难以与动目标检测兼容。压缩感知理论将目标参数估计建模作为欠定方程求解, 为该问题提供了解决思路。在相参频率捷变雷达中, 压缩感知能否准确重建目标是一个基础性问题。本文梳理了针对该问题的相关研究, 借助相变理论与相变曲线的解析表达式, 定量描述了捷变频雷达重建目标的成功概率与主要系统和目标参数之间的关系; 该理论性能边界与仿真实际所能达到的性能相接近。此外, 还探讨了现有成果在实际应用中的价值, 展望了未来研究方向。     

金属间化合物(Mg,Zn)_(12)Ce与(Mg,Zn)_(11)Ce的研究

对300℃时Mg-Zn-Ce系富镁侧化合物的成分特征、结构和相平衡关系进行了研究.结果表明,Mg-Zn-Ce富镁角存在一个Mg12Ce的二元置换固溶体(Mg,Zn)12Ce,还存在一个三元线性化合物(Mg,Zn)11Ce(τ相).(Mg,Zn)12Ce中Zn的范围为0~7.3%(原子分数),其晶体结构为体心四方晶格.三元线性化合物τ相含Zn为8.5%~43.5%(原子分数),其晶体结构为C底心正交晶格.(Mg,Zn)12Ce和τ相均与α(Mg)存在稳定的两相平衡,且在Mg-Zn-Ce系富镁角还存在三相平衡Mg+(Mg,Zn)12Ce+τ.     

带有临界增长的Kirchhoff方程极小能量变号解的存在性

为了深入研究Kirchhoff方程的性质,讨论了带有Hartree项和临界增长非线性项的Kirchhoff方程极小能量变号解的存在性。利用能量泛函在变号Nehari流形上的下确界C_λ收敛于0,得到空间E紧嵌入L~6(R~3)这一技术性结果。结果表明,利用限制变分方法和定量形变引理获得极小化序列对应的极小值点是该问题的非平凡解。研究方法在理论证明方面得到了良好的结果,对研究其他Kirchhoff方程解的存在性有一定的指导意义。     

中线在不对称负载作Y连接时的作用

通过实验分析和理论计算,从两个方面说明中线在不对称负载作星形连接时的作用.     

温敏性双亲二元共聚物的研制

用己内酯改性丙烯酸酯和丙烯酸，通过自由基聚合制备了具有温敏性的双亲二元共聚物(PAFn)，PAFn在选择性溶剂中自组装得到了聚合物纳米胶束溶液．对PAFn及胶束进行了一系列表征，研究了聚合物浓度、单体比、n值的变化等对胶束粒径的影响。同时研究了它们在醇／水介质中的相转变行为，荧光测试显示，通过自组装途径获得的胶束在醇／水介质中存在一个温度敏感区，具有明显的相转变温度．     

带电胶体系统固液相变的分子动力学研究

在修正Yukawa相互作用的基础上，采用常温分子动力学方法数值研究了带电胶体系统的大离子屏蔽效应和多分散性效应对其固液边界的影响．研究结果发现，在屏蔽长度较大时，固液相变曲线出现了明显偏差．初步定性认为这种相边界偏差现象来自于系统多体效应的增强．另外，数值研究了固液相变时键接取向序参数的变化．     

Al_(63)Cu_(25)Fe_(12)准晶体的相变及应用研究

从应用角度出发,系统地研究了Al_(63)Cu_(25)Fe_(12)合金的相变及性能特点,并初步研究了准晶体对传统铝合金表面改性的贡献。结果表明:该合金在450℃～820℃温度区间内晶体相Al_7Cu_2Fe发生同素异构转变形成稳定I相,具有较高的硬度和硬度值变化不大(650～850kgf/mm~2)的特点,可与传统铝合金复合并使其硬度和耐磨性能显著提高。     

各向异性固体弹性介质中群速度的解析表达式

通过引入一个仅仅与介质弹性常数有关的矩阵M ,将Christoffel系数矩阵分解成M和一个与波传播方向有关的矢量 P两个部分的乘积 .由此推导出适用于计算各种各向异性固体弹性介质弹性波群速度的普适解析表达式 .群速度作为弹性波波矢的函数 .在特殊对称性方向上该解析表达式的结果与已有文献的结果一致 .利用Matlab软件数值求解Chritoffel方程 ,得到对应于任意方向上的相速度 .图 2 ,参 7.     

GH220合金渗Al层的逐层相分析

通过物理—化学相分析及其它物理手段对经900℃不同时间时效的GH220合金的渗铝层进行了逐层相分析。用联立方程分别求出离表面不同深度范围内β—NiAl相γ′相的含量。通过修正比重,对取层厚度进行了合理计算。提供了渗铝层中相变趋势。本文把计算过程全部编成程序。对微处理机在相分析中的运用作了初步尝试。     

Specific anti-tumor effect induced by attenuated Salmonella typhimurium vaccine expressing extracellular region of vascular endothelial growth factor receptor 2

The purposes of this research were to study the stable expression of exogenous gene encoding therapeutic protein in attenuated Salmonella typhimurium, observe the metabolism of oral gene vaccine carried by attenuated Salmonella typhimurium in BALB/c mouse, and investigate the feasibility of prevention and treatment of tumors by the recombinant bacteria. Recombinant plasmid pcDNA3.1 VEGFR2(n1-7) was transformed into competent attenuated Salmonella typhimurium SL3261 to develop oral DNA vaccine SL3261-pcDNA3.1 VEGFR2(n1-7). To observe whether the exogenous gene can be expressed in the recombinant bacteria, PCR was performed to amplify the CMV promoter of the eukaryotic expression vector as the proof of stable expression of exogenous protein; transmission elec- tron microscopy (TEM) was applied to observe the morphology of the recombinant bacteria to confirm that the exogenous gene has no impact on the growth of the bacteria, and then BALB/c mice were immunized with the gene vaccine. After inoculation of the gene vaccine, the recombinant bacteria SL3261 could be detected in the tissues such as small intestine, colon, liver and spleen. And then, mice in each group were challenged with tumor cells. The results of animal experiment showed that tumor growth of the mice in experimental group was inhibited and survival time of immunized mice was prolonged compared with control groups. A higher lymphocyte infiltration in tumors from animals treated with DNA vaccine was observed. Immunohistochemical analysis of tumor samples revealed an en- hanced accumulation of CD8 cytotoxic T lymphocytes, as well as an increase in CD4 cells in the tumors of animals treated with the oral gene vaccine compared to tumors from control group mice. Ultrastructure of the tumor tissue showed that tumor cells in the samples of the immunized mice were well-differentiated. Our research confirmed that the exogenous gene can be stably expressed in the attenuated Salmonella typhimurium and has no impact on the growth of the recombinant bacteria; the exogenous gene can de delivered to the host by attenuated Salmonella typhimurium to produce anti-tumor effect with no obvious cytotoxity to the host. In this study, it is established that attenuated Salmonella typhimurium could be used as a vector for oral gene vaccine, and our study provided a theoretical basis for the body distribution and the metabolism of the recombinant bacteria. This strategy may provide a simple, safe and effective way for the prevention and treatment of tumors.